Myocardial contrast echocardiography: 15 Years of research and development

Research output: Contribution to journalArticle

162 Citations (Scopus)

Abstract

It has taken 15 years to move MCE from bench to bedside. In the meantime, we have gained important and fascinating insights into human coronary pathophysiology. We have also learned that any functional differences in myocardial perfusion between humans with chronic CAD and acute canine models are only quantitative. Despite structural differences in their coronary systems, clinically important qualitative differences do not exist at the functional level. We can, therefore, continued to learn a great deal about coronary pathophysiology from canines that is pertinent to humans. We have gained new knowledge regarding microbubble and ultrasound interactions. Developments based in this knowledge are accelerating in the fields of ultrasound physics and engineering with newer and better clinical systems being manufactured. We are beginning to launch multicenter studies using venous contrast agents and intermittent harmonic imaging to assess myocardial perfusion at rest and during exogenous hyperemia in patients with known and suspected CAD, including those with AMI. It is possible in the future that contrast echocardiography will become the leading tool for assessing organ perfusion in humans. The work in progress relating to endothelial function- site, and pathology-specific microbubble adherence and local drug delivery are exciting. If all goes well, we may be able to report on these advances 15 years from now!.

Original languageEnglish (US)
Pages (from-to)3745-3760
Number of pages16
JournalCirculation
Volume96
Issue number10
StatePublished - Nov 18 1997
Externally publishedYes

Fingerprint

Echocardiography
Microbubbles
Perfusion
Research
Canidae
Physics
Hyperemia
Contrast Media
Multicenter Studies
Pathology
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Physiology
  • Cardiology and Cardiovascular Medicine

Cite this

Myocardial contrast echocardiography : 15 Years of research and development. / Kaul, Sanjiv.

In: Circulation, Vol. 96, No. 10, 18.11.1997, p. 3745-3760.

Research output: Contribution to journalArticle

@article{5f299e0bd1ac432f874aaa9051722b89,
title = "Myocardial contrast echocardiography: 15 Years of research and development",
abstract = "It has taken 15 years to move MCE from bench to bedside. In the meantime, we have gained important and fascinating insights into human coronary pathophysiology. We have also learned that any functional differences in myocardial perfusion between humans with chronic CAD and acute canine models are only quantitative. Despite structural differences in their coronary systems, clinically important qualitative differences do not exist at the functional level. We can, therefore, continued to learn a great deal about coronary pathophysiology from canines that is pertinent to humans. We have gained new knowledge regarding microbubble and ultrasound interactions. Developments based in this knowledge are accelerating in the fields of ultrasound physics and engineering with newer and better clinical systems being manufactured. We are beginning to launch multicenter studies using venous contrast agents and intermittent harmonic imaging to assess myocardial perfusion at rest and during exogenous hyperemia in patients with known and suspected CAD, including those with AMI. It is possible in the future that contrast echocardiography will become the leading tool for assessing organ perfusion in humans. The work in progress relating to endothelial function- site, and pathology-specific microbubble adherence and local drug delivery are exciting. If all goes well, we may be able to report on these advances 15 years from now!.",
author = "Sanjiv Kaul",
year = "1997",
month = "11",
day = "18",
language = "English (US)",
volume = "96",
pages = "3745--3760",
journal = "Circulation",
issn = "0009-7322",
publisher = "Lippincott Williams and Wilkins",
number = "10",

}

TY - JOUR

T1 - Myocardial contrast echocardiography

T2 - 15 Years of research and development

AU - Kaul, Sanjiv

PY - 1997/11/18

Y1 - 1997/11/18

N2 - It has taken 15 years to move MCE from bench to bedside. In the meantime, we have gained important and fascinating insights into human coronary pathophysiology. We have also learned that any functional differences in myocardial perfusion between humans with chronic CAD and acute canine models are only quantitative. Despite structural differences in their coronary systems, clinically important qualitative differences do not exist at the functional level. We can, therefore, continued to learn a great deal about coronary pathophysiology from canines that is pertinent to humans. We have gained new knowledge regarding microbubble and ultrasound interactions. Developments based in this knowledge are accelerating in the fields of ultrasound physics and engineering with newer and better clinical systems being manufactured. We are beginning to launch multicenter studies using venous contrast agents and intermittent harmonic imaging to assess myocardial perfusion at rest and during exogenous hyperemia in patients with known and suspected CAD, including those with AMI. It is possible in the future that contrast echocardiography will become the leading tool for assessing organ perfusion in humans. The work in progress relating to endothelial function- site, and pathology-specific microbubble adherence and local drug delivery are exciting. If all goes well, we may be able to report on these advances 15 years from now!.

AB - It has taken 15 years to move MCE from bench to bedside. In the meantime, we have gained important and fascinating insights into human coronary pathophysiology. We have also learned that any functional differences in myocardial perfusion between humans with chronic CAD and acute canine models are only quantitative. Despite structural differences in their coronary systems, clinically important qualitative differences do not exist at the functional level. We can, therefore, continued to learn a great deal about coronary pathophysiology from canines that is pertinent to humans. We have gained new knowledge regarding microbubble and ultrasound interactions. Developments based in this knowledge are accelerating in the fields of ultrasound physics and engineering with newer and better clinical systems being manufactured. We are beginning to launch multicenter studies using venous contrast agents and intermittent harmonic imaging to assess myocardial perfusion at rest and during exogenous hyperemia in patients with known and suspected CAD, including those with AMI. It is possible in the future that contrast echocardiography will become the leading tool for assessing organ perfusion in humans. The work in progress relating to endothelial function- site, and pathology-specific microbubble adherence and local drug delivery are exciting. If all goes well, we may be able to report on these advances 15 years from now!.

UR - http://www.scopus.com/inward/record.url?scp=0030730241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0030730241&partnerID=8YFLogxK

M3 - Article

C2 - 9396479

AN - SCOPUS:0030730241

VL - 96

SP - 3745

EP - 3760

JO - Circulation

JF - Circulation

SN - 0009-7322

IS - 10

ER -